NO158677C - Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.

Info

Publication number
NO158677C
NO158677C NO850580A NO850580A NO158677C NO 158677 C NO158677 C NO 158677C NO 850580 A NO850580 A NO 850580A NO 850580 A NO850580 A NO 850580A NO 158677 C NO158677 C NO 158677C
Authority
NO
Norway
Prior art keywords
preparation
isoxsazol
derivatives
therapeutic active
analogy procedure
Prior art date
Application number
NO850580A
Other languages
English (en)
Other versions
NO850580L (no
NO158677B (no
Inventor
Friedrich-Johannes Kaemmerer
Rudolf Schleyerbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO850580L publication Critical patent/NO850580L/no
Publication of NO158677B publication Critical patent/NO158677B/no
Publication of NO158677C publication Critical patent/NO158677C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Golf Clubs (AREA)
  • Measuring Volume Flow (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
NO850580A 1984-02-17 1985-02-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater. NO158677C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843405727 DE3405727A1 (de) 1984-02-17 1984-02-17 Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO850580L NO850580L (no) 1985-08-19
NO158677B NO158677B (no) 1988-07-11
NO158677C true NO158677C (no) 1988-10-19

Family

ID=6228020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850580A NO158677C (no) 1984-02-17 1985-02-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.

Country Status (19)

Country Link
US (1) US4636513A (no)
EP (1) EP0152868B1 (no)
JP (1) JPS60193973A (no)
KR (1) KR850006411A (no)
AT (1) ATE44142T1 (no)
AU (1) AU572612B2 (no)
CA (1) CA1247616A (no)
DE (2) DE3405727A1 (no)
DK (1) DK165981C (no)
ES (1) ES8602776A1 (no)
FI (1) FI81094C (no)
GR (1) GR850416B (no)
HU (1) HU194192B (no)
IL (1) IL74351A (no)
MA (1) MA20352A1 (no)
NO (1) NO158677C (no)
NZ (1) NZ211139A (no)
PH (1) PH21434A (no)
PT (1) PT79969B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
IT1228288B (it) * 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
EP0527736B1 (de) * 1990-05-18 1997-04-16 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
ZA913762B (en) 1990-05-18 1992-01-29 Hoechst Ag Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
GB9219779D0 (en) * 1992-09-18 1992-10-28 Rhone Poulenc Agriculture Compositions of new matter
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
DE59912559D1 (de) 1999-07-02 2005-10-20 Cognis Ip Man Gmbh Mikrokapseln - III

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE634286C (de) * 1935-02-23 1936-08-26 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren
US2126329A (en) * 1936-03-20 1938-08-09 Hoffmann La Roche Amide derivatives of isoxazole carboxylic acids
DE653835C (de) * 1936-03-20 1937-12-03 Hoffmanni La Roche & Co Akt Ge Verfahren zur Darstellung amidartiger Abkoemmlinge von Isoxazolcarbonsaeuren
US2212767A (en) * 1938-01-17 1940-08-27 Hoffmann La Roche Amide derivatives of 3,5-dimethylisoxazole carboxylic acids
DE2524959C2 (de) * 1975-06-05 1983-02-10 Hoechst Ag, 6000 Frankfurt 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel

Also Published As

Publication number Publication date
EP0152868A3 (en) 1986-10-08
ATE44142T1 (de) 1989-07-15
DK165981B (da) 1993-02-22
ES540438A0 (es) 1985-12-01
AU572612B2 (en) 1988-05-12
FI850613A0 (fi) 1985-02-14
EP0152868B1 (de) 1989-06-21
CA1247616A (en) 1988-12-28
AU3878585A (en) 1985-09-05
PT79969B (de) 1987-02-02
IL74351A (en) 1988-11-15
NZ211139A (en) 1988-04-29
DE3571130D1 (en) 1989-07-27
ES8602776A1 (es) 1985-12-01
FI850613L (fi) 1985-08-18
HU194192B (en) 1988-01-28
FI81094C (fi) 1990-09-10
IL74351A0 (en) 1985-05-31
NO850580L (no) 1985-08-19
GR850416B (no) 1985-06-18
NO158677B (no) 1988-07-11
PT79969A (de) 1985-03-01
JPH03866B2 (no) 1991-01-09
US4636513A (en) 1987-01-13
MA20352A1 (fr) 1985-10-01
PH21434A (en) 1987-10-15
DE3405727A1 (de) 1985-08-22
JPS60193973A (ja) 1985-10-02
EP0152868A2 (de) 1985-08-28
DK165981C (da) 1993-07-26
DK74085A (da) 1985-08-18
FI81094B (fi) 1990-05-31
DK74085D0 (da) 1985-02-15
KR850006411A (ko) 1985-10-05
HUT37767A (en) 1986-02-28

Similar Documents

Publication Publication Date Title
DE3572820D1 (en) 1,4:3,6-dianhydro-hexite derivatives, process for their preparation and their use as medicaments
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
NO158677C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.
ES8609286A1 (es) Un metodo para preparar un compuesto de morfolinol
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
ZA80166B (en) Hexahydro-1,4-oxazepines,their preparation,and drugs containing these compounds
BE896098A (fr) Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes
GR3001965T3 (en) Salts of 6-piperidino-2,4-diaminopyrimidin-3-oxide and of derivatives of thiamorpholin-3-on-5-carboxylic acid, their cosmetical and medicinal use
ES8303405A1 (es) Procedimiento de preparacion de derivados de quinidina.